BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22155000)

  • 1. A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels.
    Liu Y; Zhang J; Yu L; Cao F; Rao J; Li J; Jiang C; Falck JR; Jacobs ER; Zhu D
    Pulm Pharmacol Ther; 2012 Feb; 25(1):69-76. PubMed ID: 22155000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable EET urea agonist and soluble epoxide hydrolase inhibitor regulate rat pulmonary arteries through TRPCs.
    Liu Y; Wang R; Li J; Rao J; Li W; Falck JR; Manthati VL; Medhora M; Jacobs ER; Zhu D
    Hypertens Res; 2011 May; 34(5):630-9. PubMed ID: 21307870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of aortic KIR6.1 and SUR2B in hypertension does not correlate with changes in the functional role of K(ATP) channels.
    Blanco-Rivero J; Gamallo C; Aras-López R; Cobeño L; Cogolludo A; Pérez-Vizcaino F; Ferrer M; Balfagon G
    Eur J Pharmacol; 2008 Jun; 587(1-3):204-8. PubMed ID: 18471810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.
    Ploug KB; Boni LJ; Baun M; Hay-Schmidt A; Olesen J; Jansen-Olesen I
    Br J Pharmacol; 2008 May; 154(1):72-81. PubMed ID: 18332850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine vasopressin inhibits Kir6.1/SUR2B channel and constricts the mesenteric artery via V1a receptor and protein kinase C.
    Shi W; Cui N; Shi Y; Zhang X; Yang Y; Jiang C
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R191-9. PubMed ID: 17428891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
    Cui Y; Tinker A; Clapp LH
    Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
    Insuk SO; Chae MR; Choi JW; Yang DK; Sim JH; Lee SW
    Int J Impot Res; 2003 Aug; 15(4):258-66. PubMed ID: 12934053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoflurane activates sarcolemmal adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells: a role for protein kinase A.
    Tanaka K; Kawano T; Nakamura A; Nazari H; Kawahito S; Oshita S; Takahashi A; Nakaya Y
    Anesthesiology; 2007 May; 106(5):984-91. PubMed ID: 17457130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged exposure to methylglyoxal causes disruption of vascular KATP channel by mRNA instability.
    Yang Y; Li S; Konduru AS; Zhang S; Trower TC; Shi W; Cui N; Yu L; Wang Y; Zhu D; Jiang C
    Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1045-54. PubMed ID: 22972803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of etomidate and midazolam on vascular adenosine triphosphate-sensitive potassium channels: isometric tension and patch clamp studies.
    Nakamura A; Kawahito S; Kawano T; Nazari H; Takahashi A; Kitahata H; Nakaya Y; Oshita S
    Anesthesiology; 2007 Mar; 106(3):515-22. PubMed ID: 17325510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cirrhosis decreases vasoconstrictor response to electrical field stimulation in rat mesenteric artery: role of calcitonin gene-related peptide.
    Blanco-Rivero J; Márquez-Rodas I; Sastre E; Cogolludo A; Pérez-Vizcaíno F; del Campo L; Nava MP; Balfagón G
    Exp Physiol; 2011 Mar; 96(3):275-86. PubMed ID: 21148625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
    Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 acts via protein kinase C to block KATP channels in rabbit coronary and pulmonary arterial smooth muscle cells.
    Park WS; Ko EA; Han J; Kim N; Earm YE
    J Cardiovasc Pharmacol; 2005 Feb; 45(2):99-108. PubMed ID: 15654257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP-sensitive K(+) channels composed of Kir6.1 and SUR2B subunits in guinea pig gastric myocytes.
    Sim JH; Yang DK; Kim YC; Park SJ; Kang TM; So I; Kim KW
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G137-44. PubMed ID: 11751167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells.
    Archer SL; Wu XC; Thébaud B; Nsair A; Bonnet S; Tyrrell B; McMurtry MS; Hashimoto K; Harry G; Michelakis ED
    Circ Res; 2004 Aug; 95(3):308-18. PubMed ID: 15217912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KATP-channel-induced vasodilation is modulated by the Na,K-pump activity in rabbit coronary small arteries.
    Glavind-Kristensen M; Matchkov V; Hansen VB; Forman A; Nilsson H; Aalkjaer C
    Br J Pharmacol; 2004 Dec; 143(7):872-80. PubMed ID: 15504751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
    Fujita H; Ogura T; Tamagawa M; Uemura H; Sato T; Ishida A; Imamaki M; Kimura F; Miyazaki M; Nakaya H
    Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
    Russ U; Hambrock A; Artunc F; Löffler-Walz C; Horio Y; Kurachi Y; Quast U
    Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced effectiveness of HMR 1098 in blocking cardiac sarcolemmal K(ATP) channels during metabolic stress.
    Rainbow RD; Norman RI; Hudman D; Davies NW; Standen NB
    J Mol Cell Cardiol; 2005 Oct; 39(4):637-46. PubMed ID: 16099467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.